New tool to predict breast cancer recurrences

A new tool combining traditional pathology with machine learning could predict which breast cancer patients actually need surgery. The technology, reported in the November issue of American Journal of Physiology — Cell Physiology (vol. 319: C910-C921;, could spare women from unnecessary treatments, reduce medical expenses, and lead to a new generation of drugs to stop breast cancer recurrences.

Ductal carcinoma in situ (DCIS) of the breast, an early form of disease also known as stage 0 breast cancer, is a diagnosis that only sometimes leads to invasive breast cancer. But only some patients need surgery, chemotherapy and/or radiotherapy, and the rest could be sent home. Predicting the outcomes of patients with early forms of cancer has been a major scientific problem for decades.

Professor Howard Petty and Ms. Alexandra Kraft, his research assistant, both of the University of Michigan, have just

Read More

Cambridge start-up raises fresh cash for breast cancer technology

A Cambridge-based start-up that is developing technology to help simplify breast cancer treatments has raised £15m in new cash, amid growing fears of a backlog in the NHS for patients.

Endomag has raised funds from existing investors, including Draper Esprit, which led the round. It takes the total raised by the company since it was founded to more than £30m. 

The company focuses on breast cancer and has developed tools that help surgeons find the tissue they are looking for, be that tumours or lymph nodes implicated in the spread of the tumour. Traditionally, surgeons use nuclear medicine to find these tissues ahead of surgery, but Endomag’s technology relies on magnetism, using magnetic seeds to mark potentially cancerous tissue, which can then be located later.

Endomag said this allows for less unnecessary surgery, because it can be easier to locate clinically suspicious nodes. It also means the process of locating

Read More

Breast Implants Market 2020 Trends, Size, Growth Insight, Share, Emerging Technologies, Share, Competitive, Regional, And Global Forecast To 2026

The MarketWatch News Department was not involved in the creation of this content.

Nov 24, 2020 (The Expresswire) —
Global“Breast Implants Market”(2020-2026) status and position of worldwide and key regions, with perspectives of manufacturers, regions, product types and end industries; this report analyses the topmost companies in worldwide and main regions, and splits the Breast Implants market by product type and applications/end industries.The Breast Implants market trend research process includes the analysis of different factors affecting the industry, with the government policy, competitive landscape, historical data, market environment, present trends in the market, upcoming technologies,technological innovation, and the technical progress in related industry, and market risks, market barriers,opportunities, and challenges.

Get a sample PDF of the report at

The global Breast Implants market is anticipated to rise at a considerable rate during the forecast period, between 2020 and 2026. In 2020, the market was growing at

Read More

Greenwich LifeSciences Announces Second Publication and Second Poster Presentation of Phase III Clinical Trial of Potential Breakthrough Technology for Recurring Breast Cancer

STAFFORD, Texas–(BUSINESS WIRE)–Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the “Company”), a clinical-stage biopharmaceutical company focused on the development of GP2, an immunotherapy to prevent breast cancer recurrences in patients who have previously undergone surgery, today announced the publication of a second abstract at the San Antonio Breast Cancer Symposium (SABCS), jointly authored by Professor Mothaffar F. Rimawi, the Global Principal Investigator of the GP2 Phase III clinical trial, and the Executive Medical Director and Co-Leader of the Breast Cancer Program at the Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine, and Professor C. Kent Osborne, Tina and Dudley Sharp Chair in Oncology and the founding Director of the Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine. The abstract will be displayed as the Company’s second poster on Wednesday, December 9, 2020 in a virtual format with an introductory audio track.

The abstract highlights

Read More

Breakthrough technology boosts breast cancer diagnosis

Breakthrough technology boosts breast cancer diagnosis
The technology in use. Credit: 4D Path

New technology which helps doctors more accurately diagnose breast cancer has been recognised by the US Food & Drugs Administration (FDA) for its exceptional potential clinical value.

The 4-D Q-plasia OncoReader Breast uses digitised pathology slides of breast cancer tissue to diagnose disease with improved accuracy, effectively acting as an intelligent aid for clinical histopathologists. The FDA status means the software is now on a fast track to full market approval in the US and will boost progress to regulatory approval and clinical adoption in the UK and globally.

Developed through a three-year partnership between the University and 4-D Path, a Boston company producing computer-aided cancer diagnostic products, the device has received FDA Breakthrough Device Designation.

The sought-after status is an acknowledgement by the FDA that a test, drug or device is a breakthrough in innovation and stands to improve the current standard

Read More

Breast Imaging Market 2020 Size, Share, Analysis by Opportunities, Sales Revenue, Emerging Technologies and Trends by Forecast to 2023

The MarketWatch News Department was not involved in the creation of this content.

Nov 16, 2020 (Heraldkeepers) —
The Report Presents a Complete Picture of the Global Breast Imaging Market to Readers, including a Detailed Overview of the Market’s Historical Growth Trajectory and Present Condition in order to Present Forecasts for the Market’s likely Movement over the Coming Years.

Aurora Imaging Technology, Inc., Sonocine, Inc., General Electric Company, Dilon Technologies, Inc., Koninklijke Philips N.V., Gamma Medica, Inc., Toshiba Corporation, Fujifilm Holdings Corporation, Hologic, Inc., Siemens, and others are prominent names in the global breast imaging market. Partnerships are being increasingly seen for players to showcase their latest products. For instance, Fujifilm has inked a partnership contract with Max Healthcare for training doctors in the latest breast imaging technology.

Get Free Sample Copy at

Industry News

Mammography is one of the latest technologies for identifying lesions in heavy breasts. 3D

Read More

‘I want to give my child the best’: the race to grow human breast milk in a lab | Breastfeeding

Dr Leila Strickland became a mother when she was a few months away from completing her postdoctorate fellowship in cell biology at Stanford University. She spent the first three months of her son’s life “at home on maternity leave, relentlessly struggling to breastfeed. I was having a hard time producing enough milk.” She never expected to find feeding her baby a greater challenge than advanced cytology.

“My mom breastfed me and my sister until we were over two years old. All my life, I’d fully embraced the proposition that breast milk is the best nutrition for a baby, and that this is what I would feed my baby.” Lactation consultants, paediatricians and well-meaning friends told her to just keep trying. “Because I was so unprepared for it, I found it really isolating. I felt like there was something wrong with me.”

Eventually – reluctantly – Strickland decided to bottle-feed

Read More

Technology helps find breast cancer faster | News

Caldwell Medial Center has new technology that will help detect breast cancer faster, which will help treatment and healing begin sooner.

The Genius 3D Mammography unit provides a fast, non-invasive breast examination that scans the breast and provides low-dose X-ray images for better resolution and definition of the 3-dimensional images.

The medical center has had the machine since late September and is its first 3-D mammography unit. The estimated cost was about $360,000.

“People will love it,” Imaging Manager Robbie Wells said. “It is more comfortable, and it’s curved so it fits around the breast better. We’ve heard really good things about it.”

Pam Talley is the chief mammography technician at Caldwell Medical Center who will work with patients who come for breast exams.

“It takes 3-D images, and the camera moves back and forth,” she said. “It takes a series of images, then it comes back up straight and

Read More

Breast Implant Market 2020 Technology, Future Trends, Market Opportunities 2030

Market Industry Reports (MIR) has published a new report titled “Breast Implant Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019-2030.” According to the report, the global breast implants market is estimated to account for over US$ 2.7 billion in 2019. It is anticipated to grow at a CAGR of 6.1% from 2019 to 2030.

Significant market growth can be attributed to the increasing number of breast augmentation procedures. Moreover, factors such as the rising prevalence of breast cancer, the launch of new products, and technological advancements are anticipated to boost market growth over the forecast period. Extensive research & development activities by major companies and universities across the globe for developments in breast implant technology with an aim to increase safety and precision are expected to contribute to market expansion. In June 2019, GC Aesthetics announced the launch of Eve 4.0, a digital consultation solution that

Read More

What do breast cancer cells feel inside the tumor? New technique may lead to early and improved cancer detection and mapping — ScienceDaily

Using a new technique, a team of McGill University researchers has found tiny and previously undetectable ‘hot spots’ of extremely high stiffness inside aggressive and invasive breast cancer tumours. Their findings suggest, for the first time, that only very tiny regions of a tumor need to stiffen for metastasis to take place. Though still in its infancy, the researchers believe that their technique may prove useful in detecting and mapping the progression of aggressive cancers.

“We are now able to see these features because our approach allows us to take measurements within living, intact, 3D tissues,” says Chris Moraes, from McGill University’s Department of Chemical Engineering, a Canada Research Chair and senior author on a recent research paper in Nature Communications. “When tissue samples are disrupted in any way, as is normally required with standard techniques, signs of these ‘hot spots’ are eliminated.”

“Smart” hydrogels provide information about cancer

Read More